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An outbreak of dengue-like syndrome occurred in Toa-
masina from January through March 2006. Dengue type l 
or chikungunya viruses were detected in 38 of 55 patients 
sampled. Aedes albopictus was the only potential vector col-
lected. Of 4,242 randomly selected representative residents 
interviewed retrospectively, 67.5% reported a dengue-like 
syndrome during this period.
A
rbovirus infections, arthropod-transmitted viral diseas-
es, are common health risks in tropical and subtropi-
cal areas. Since early 2006, chikungunya fever, a crippling 
mosquito-borne disease, has emerged in the southwestern 
nations of the Indian Ocean. An epidemic started in Ke-
nya in 2004 and in Moroni (Comoros Island) early in 2005 
(1). Increasing incidence of the disease was ﬁ  rst reported in 
April 2005 in the French island of Réunion. Approximately 
5,000 cases were reported up to December, when a massive 
epidemic began (2). By the ﬁ  rst week of March 2006, the 
virus had spread to the islands of Seychelles, Mauritius, 
and Mayotte (1).
During that same period, in January 2006, an outbreak 
of denguelike syndrome (DLS) was reported in Toamasina, 
on Madagascar’s east coast. The results of the virologic and 
entomologic investigations are reported below. A retro-
spective cross-sectional study was also conducted to assess 
the extent of the outbreak.
The Study
Laboratory investigation began when the alert was 
given in January 2006. Serum samples were obtained from 
patients who had fever lasting <5 days and at least 3 of 
the following symptoms: headache, myalgia, arthralgia, 
retroorbital pain, or rash. Serum samples were sent from 
the health centers in Toamasina to the Institut Pasteur de 
Madagascar in Antananarivo in dry nitrogen containers 
and then stored at –80°C. Altogether, 55 patients were 
sampled; second samples were obtained from 14 patients. 
RNA extraction and chikungunya virus (CHIKV) detection 
were performed as previously described (1). Dengue virus 
(DENV) detection was performed according to the tech-
nique of Lanciotti et al. (3). Immunoglobulin (Ig) M and 
IgG against CHIKV and DENV were detected by ELISA 
as previously described (4).
Entomologic investigation was conducted February 14–
17, 2006, to determine the abundance of DENV and CHIKV 
in urban mosquito vectors. Five neighborhoods in which hu-
man cases of DLS had been reported were explored. Mos-
quito larvae collected by manual method at all potential lar-
vae breeding sites, inside and outside homes, were reared to 
obtain adults for species identiﬁ  cation. The Breteau Index 
and Container Index were then calculated for the Aedes spp. 
identiﬁ  ed. Collection of adult mosquitoes was performed 
indoors with pyrethrum spray catches and outside with US 
Centers for Disease Control and Prevention (CDC) light trap 
and oral aspirators (for hand catches).
Epidemiologic study was conducted March 21–28, 
2006. A retrospective cross-sectional study was performed 
on Toamasina’s population (≈200,000 inhabitants) by using 
a 2-stage cluster sampling (n = 378) at the neighborhood 
level. Every member of the household was interviewed 
with a standardized questionnaire based on personal history 
of sickness and travel. Data for children or those absent 
were given by present adults. Description of fever episodes 
and other clinical signs occurring after January 1, 2006, 
were collected. DLS is deﬁ  ned as a febrile illness and at 
least 2 other signs or symptoms: headache, joint pain, body 
pain, rash, and asthenia. Data were entered and analyzed by 
using EpiInfo (CDC, Atlanta, GA, USA).
DENV-1 or CHIKV was detected in 38 of 55 pa-
tients sampled. Co-infections were detected in 10 patients 
(Figure 1). Consequently, the outbreak was deﬁ  nitively at-
tributed to DENV-1 and CHIKV.
Aedes albopictus was the unique DENV and CHIKV 
vector found. Only 6 adults of this mosquito species were 
caught. All of the positive larval breeding sites consisted 
of artiﬁ  cial containers (drums, buckets, coconut shells, dis-
carded cans, tires, pots, and wet containers). Tires were the 
most important breeding sites identiﬁ  ed (68%, n = 96). The 
Container and Breteau Indexes were 38.6 and 84.0, respec-
tively. Ae. albopictus mosquito pools (n = 23) were tested 
by processing with CHIKV and DENV reverse transcrip-
tion–PCRs. Five pools, including adults reared from larvae, 
were found to be CHIKV positive. However, no isolate was 
obtained from these pools by using AP61 cells.
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27 neighborhoods of Toamasina participated in the study. 
The mean age of participants was 24.9 years (95% conﬁ  -
dence interval [CI] 24.4–25.4). The sex ratio (male:female) 
was 0.87. Most of the participants (n = 3,084; 72.7%) re-
ported >1 previous episode of fever from January through 
March 2006. DLS was suspected in 2,863 (67.5%) resi-
dents, among whom 41 (1.4%) were hospitalized.
The estimated epidemic curve identiﬁ  ed 2 outbreak 
periods. This distribution was emphasized by the report of 
a second episode of DLS by 110 patients. The peaks of 
the 2 periods were estimated in weeks 7 and 11 (Figure 2). 
The percentage of DLS in the studied population was high 
(40.2%–76.1%), regardless of age or sex. Rates of DLS did 
no differ in male and female patients. However, patients 
with DLS were older (mean age 26.8 years, 95% CI 26.2–
27.4) than nonaffected persons (mean age 20.8 years, 95% 
CI 19.9–21.7; p<0.01). The most common features of the 
ﬁ  rst episode of DLS (n = 110) were fever (100%), head-
ache (96.4%), joint pain (79.1%), asthenia (76.4%), my-
algia (76.4%), pruritus (40.0%), and rash (13.6%). When 
these 110 patients exhibited a second episode of DLS, the 
most common clinical features were fever (100%), head-
ache (90.0%), myalgia (73.6%), joint pain (68.2%), and 
pruritus (28.2%).
Conclusions
An outbreak caused by both CHIKV and DENV-1 oc-
curred in Madagascar. The notiﬁ  cation of CHIKV in the 
island occurred during a large epidemic that hit the south-
western islands of the Indian Ocean. The Malagasy CHIKV 
E1 partial nucleotide sequences were similar to those of 
the Indian Ocean outbreak (Réunion, Seychelle, Mayotte, 
Mauritius islands) and represented a distinct clade within 
the large east-central and South African phylogroup (1). 
DENV-1 was also circulating during this outbreak in the 
eastern part of the island. A few DENV-1 isolates were al-
ready obtained from patients visiting the northwestern coast 
of the island in early 2005. Molecular characterization of 
these isolates showed that they were similar to DENV-1 
strains circulating in 2004 in Réunion and indicated their 
regional origin (H. Zeller, pers. comm.).
Ae. albopictus was the only urban vector of DENV or 
CHIKV detected during this outbreak. This species had al-
ready been reported in the eastern coast of Madagascar (5). 
Individual mosquitoes from this species, sampled in Anta-
nanarivo (in the highlands of Madagascar) in the 1970s and 
more recently in northern Madagascar, are highly suscepti-
ble to CHIKV and DENV (6–8). This situation, associated 
with a high larvae index and probably a nonimmune popu-
lation, led to a high rate of transmission, as indicated by 
the high percentage of DENV-1 and CHIKV co-infection 
detected in the 55 patients tested (18%) and the high attack 
rate (67.5%).
The cocirculation of DENV-1 and CHIKV during the 
period may explain the 2 peaks observed in the epidemic 
curve. However, because the study was based on clinical 
observations alone, we could not measure the relative con-
tribution for each peak. All age groups were affected. This 
result is likely due in part to the recent emergence of these 
viruses in Madagascar. However, children and particularly 
those <1 year of age might be less exposed to Ae. albopic-
tus because they are often indoors  and are fully covered. 
Underreporting could also be an explanation for this mod-
erate prevalence in children.
During this epidemic, vector control measures (remov-
al of tires from rooftops, information campaign, education 
of the community) were undertaken by the local authori-
ties. After the outbreak, the Malagasy Ministry of Health 
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Figure 1. Laboratory diagnosis, dengue (DENV) and chikungunya 
(CHIKV) viruses, for 55 patients sampled, Madagascar, 2006. RT-
PCR, reverse transcription–PCR; Ig, immunoglobulin.
Figure 2. Outbreak curve of dengue and chikungunya fevers in 
Toamasina, January 1–March 28, 2006.
0
50
100
150
200
250
300
350
400
450
500
5 2 123456789 1 0 1 1 1 2 1 3
Weeks
N
o
.
 
c
a
s
e
s
0
5
10
15
20
25
30
 
N
o
.
 
c
a
s
e
s
  Global epidemic curve
  First denguelike syndrome (n = 110)
  Second denguelike syndrome (n = 110)
 Dengue and Chikungunya Fevers, Madagascar
implemented a sentinel surveillance system to monitor and 
control epidemic arboviral diseases. However, the emer-
gence of this regional outbreak also demonstrates the need 
for coordinating surveillance systems in the islands in the 
southwestern Indian Ocean.
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